New pill targets lung inflammation in sarcoidosis

NCT ID NCT06205121

Recruiting now Disease control Sponsor: Molecure S.A. Source: ClinicalTrials.gov ↗

Summary

This study is testing whether a new oral drug called OATD-01 can help control active lung sarcoidosis. About 96 adults with symptomatic lung sarcoidosis will take either the drug or a placebo pill for 12 weeks. Researchers will use special scans to see if the drug reduces lung inflammation and check if it improves breathing and quality of life.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Molecure Investigative Site
WITHDRAWN

Birmingham, Alabama, 35209, United States
Molecure Investigative Site
WITHDRAWN

Kansas City, Kansas, 66062, United States
Molecure Investigative Site
RECRUITING

Baltimore, Maryland, 21224, United States
Molecure Investigative Site
WITHDRAWN

Rochester, Minnesota, 55905, United States
Molecure Investigative Site
RECRUITING

Cleveland, Ohio, 44195, United States
Molecure Investigative Site
RECRUITING

Philadelphia, Pennsylvania, 19140, United States
Molecure Investigative Site
RECRUITING

Charleston, South Carolina, 29425, United States
Molecure Investigative Site
WITHDRAWN

Vejle, 7100, Denmark
Molecure Investigative Site
WITHDRAWN

Bobigny, 93000, France
Molecure Investigative Site
RECRUITING

Montpellier, 34295, France
Molecure Investigative Site
RECRUITING

Paris, 75013, France
Molecure Investigative Site
RECRUITING

Paris, 75015, France
Molecure Investigative Site
RECRUITING

Essen, 45239, Germany
Molecure Investigative Site
RECRUITING

Freiburg im Breisgau, 79106, Germany
Molecure Investigative Site
RECRUITING

Mainz-GE, 55131, Germany
Molecure Investigative Site
WITHDRAWN

Corfu, 49100, Greece
Molecure Investigative Site
RECRUITING

Heraklion, 71500, Greece
Molecure Investigative Site
RECRUITING

Pátrai, 26500, Greece
Molecure Investigative Site
RECRUITING

Thessaloniki, 57010, Greece
Molecure Investigative Site
RECRUITING

Nieuwegein, 3435 CM, Netherlands
Molecure Investigative Site
RECRUITING

Rotterdam, 3015 GD, Netherlands
Molecure Investigative Site
RECRUITING

Bergen, 5009, Norway
Molecure Investigative Site
RECRUITING

Oslo, 1478, Norway
Molecure Investigative Site
RECRUITING

Birmingham, B15 2GW, United Kingdom
Molecure Investigative Site
WITHDRAWN

Cambridge, CB2 0AY, United Kingdom
Molecure Investigative Site
RECRUITING

Edinburgh, EH16 4SA, United Kingdom
Molecure Investigative Site
RECRUITING

London, SE5 9RS, United Kingdom
Molecure Investigative Site
RECRUITING

London, SW3 6JY, United Kingdom

Conditions

Explore the condition pages connected to this study.

PULMONARY SARCOIDOSIS